Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Medical College of Wisconsin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Bayer
Children's Oncology Group
National Cancer Institute (NCI)
Y-mAbs Therapeutics
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Children's Oncology Group
Celgene
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Eli Lilly and Company